BRIEF published on 07/03/2024 at 17:50, 4 months 17 days ago Declaration relating to voting rights as of June 30, 2024 Euronext Paris Share Capital Voting Rights AUGROS COSMETIC PACKAGING
BRIEF published on 06/03/2024 at 18:05, 5 months 17 days ago Publication of voting rights and shares of AUGROS COSMETIC PACKAGING Euronext Paris Share Capital Actions AUGROS COSMETIC PACKAGING Right To Vote
BRIEF published on 05/24/2024 at 18:05, 5 months 27 days ago Augros Cosmetic Packaging: 2023 Results and Outlook Financial Results Outlook Investments Augros Cosmetic
BRIEF published on 05/02/2024 at 18:00, 6 months 18 days ago Declaration of AUGROS COSMETIC PACKAGING on its voting rights as of April 2024 Euronext Paris Share Capital Voting Rights Investors AUGROS COSMETIC PACKAGING
BRIEF published on 04/08/2024 at 17:55, 7 months 12 days ago Declaration of voting rights of AUGROS COSMETIC PACKAGING as of March 31, 2024 Euronext Paris Voting Rights Corporate Governance Financial Market AUGROS COSMETIC PACKAGING
Published on 11/21/2024 at 14:00, 15 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 15 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 15 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 45 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 40 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 55 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
